Person:
GÜNEŞ BAYIR, AYŞE

Loading...
Profile Picture
Status
Organizational Units
Job Title
First Name
AYŞE
Last Name
GÜNEŞ BAYIR
Name
Email Address
Birth Date

Search Results

Now showing 1 - 10 of 10
No Thumbnail Available
PublicationMetadata only

Thermal and Biochemical Effects of Low Level Electromagnetic Radiation on Rat Brains and Bodies

2014-06-01, KIZILTAN, HURİYE ŞENAY, ERİŞ, ALİ HİKMET, MAYADAĞLI, ALPASLAN, GÜNEŞ BAYIR, AYŞE, YAGCI, B, TAŞPINAR, ÖZGÜR, AYDIN, TEOMAN, TRABZON, M, KIZILTAN, HURİYE ŞENAY, ERİŞ, ALİ HİKMET, MAYADAĞLI, ALPASLAN, GÜNEŞ BAYIR, AYŞE, AYDIN, TEOMAN

No Thumbnail Available
PublicationMetadata only

Medical ozone and radiotherapy in a peritoneal, erlich-ascites, tumor-cell model

2015-01-01, KIZILTAN, HURİYE ŞENAY, BAYIR, Ayşe Güneş, Yucesan, GÜL, Eris, ALİ HİKMET, KARATOPRAK, CUMALİ, İDİN, Kadir, AYDIN, TEOMAN, AKÇAKAYA, ADEM, MAYADAĞLI, ALPASLAN, KIZILTAN, HURİYE ŞENAY, GÜNEŞ BAYIR, AYŞE, YÜCESAN, GÜL, ERİŞ, ALİ HİKMET, KARATOPRAK, CUMALİ, AYDIN, TEOMAN, AKÇAKAYA, ADEM, MAYADAĞLI, ALPASLAN

No Thumbnail Available
PublicationMetadata only

Self-Reported Physical Activity and Dietary Habits in Turkish Cancer Patients Receiving Radiotherapy: A Pilot Study

2017-08-01, GÜNEŞ BAYIR, AYŞE, KIZILTAN, HURİYE ŞENAY, GÜNEY, MERVE, MAYADAĞLI, ALPASLAN, GÜNEŞ BAYIR, AYŞE, KIZILTAN, HURİYE ŞENAY, MAYADAĞLI, ALPASLAN

No Thumbnail Available
PublicationMetadata only

Can Nigella Sativa and Pure Honey Improved Chemoradiotherapy Effects in Advanced Pancreatic Cancer

2017-12-01, KIZILTAN, HURİYE ŞENAY, KÜRŞAT, TÜRKDOĞAN, GÜNEŞ BAYIR, AYŞE, ERİŞ, ALİ HİKMET, MAYADAĞLI, ALPASLAN, KIZILTAN, HURİYE ŞENAY, GÜNEŞ BAYIR, AYŞE, ERİŞ, ALİ HİKMET, MAYADAĞLI, ALPASLAN

No Thumbnail Available
PublicationMetadata only

Pain management with Radiotherapy and ozone with high dose vitamin C therapy in a case of bone metastatis of breast cancer patient

2018-02-01, KIRSEVER, ESRA, KIZILTAN, HURİYE ŞENAY, YILMAZ, RABİYE, GÜNEŞ BAYIR, AYŞE, BAŞIBÜYÜK, MERYEM, ÇAKIR, FATMA BETÜL, GÜL, KÜRŞAT, ŞİMŞEK, MUHARREM, KIZILTEPE, AYŞE, GÜMÜŞ, ASLI, KALAYCI, KÜBRA, AKÇAKAYA, ADEM, MAYADAĞLI, ALPASLAN, AYDOĞDU, İBRAHİM, ALTINOK SÜT, PELİN, AYDIN, TEOMAN, KIZILTAN, HURİYE ŞENAY, ERİŞ, ALİ HİKMET, GÜNEŞ BAYIR, AYŞE, BAŞIBÜYÜK, MERYEM, ÇAKIR, FATMA BETÜL, GÜL, KÜRŞAT, GÜMÜŞ, ASLI, KALAYCI, KÜBRA, AKÇAKAYA, ADEM, MAYADAĞLI, ALPASLAN, AYDOĞDU, İBRAHİM, ALTINOK SÜT, PELİN, AYDIN, TEOMAN

No Thumbnail Available
PublicationMetadata only

Successfull Pain Management with Radiotherapy and Ozone Therapy in a Case of Metastatic, Chemotherapy Resistant Sino-Nasal Mucosal Malignant Melanoma

2017-03-01, KIZILTAN, HURİYE ŞENAY, GÜNEŞ BAYIR, AYŞE, ERİŞ, ALİ HİKMET, BAŞIBÜYÜK, MERYEM, MAYADAĞLI, ALPASLAN, AKÇAKAYA, ADEM, ÇAKIR, FATMA BETÜL, AYDIN, TEOMAN, GÜL, KÜRŞAT, KARABAL, ESRA, ŞİMŞEK, MUHARREM, KIZILTAN, HURİYE ŞENAY, GÜNEŞ BAYIR, AYŞE, ERİŞ, ALİ HİKMET, BAŞIBÜYÜK, MERYEM, MAYADAĞLI, ALPASLAN, AKÇAKAYA, ADEM, ÇAKIR, FATMA BETÜL, AYDIN, TEOMAN, GÜL, KÜRŞAT, KARABAL, ESRA

No Thumbnail Available
PublicationMetadata only

Radioprotectant and Cytotoxic Effects of Spirulina in Relapsed Verrucous Vulvar Cancer: A Case Report

2015-01-01, Kiziltan, HURİYE ŞENAY, Bayir, Ayse Gunes, TAŞPINAR, Ozgur, Yucesan, GÜL, Tastekin, Didem, SONMEZ, Fatma Cavidan, Coban, GANİME, Kilic, GÖKHAN, Eris, ALİ HİKMET, Aydin, TEOMAN, Akcakaya, ADEM, Mayadagli, ALPASLAN, KIZILTAN, HURİYE ŞENAY, GÜNEŞ BAYIR, AYŞE, YÜCESAN, GÜL, ÇOBAN, GANİME, KILIC, GÖKHAN, ERİŞ, ALİ HİKMET, AYDIN, TEOMAN, AKÇAKAYA, ADEM, MAYADAĞLI, ALPASLAN

Context . The treatment of relapsed verrucous vulvar cancer (VVC) is difficult. When vulvar cancer relapses, the treatment response is low for second-line treatments. Conversely, toxicity is high. Therefore, scientists need to identify different treatment methods.

Loading...
Thumbnail Image
PublicationOpen Access

Outcome of Daily Cisplatin with Thoracic Chemoradiotherapy in Advanced Non-small Cell Lung Cancer Patients with Comorbid Disorders: a Pilot Study

2014-01-01, Kiziltan, HURİYE ŞENAY, Bayir, Ayse Gunes, TAŞTEKİN, Didem, Coban, GANİME, Eris, ALİ HİKMET, Aydin, TEOMAN, MAYADAGLI, Alparslan, KIZILTAN, HURİYE ŞENAY, GÜNEŞ BAYIR, AYŞE, ÇOBAN, GANİME, ERİŞ, ALİ HİKMET, AYDIN, TEOMAN, MAYADAĞLI, ALPASLAN

Background: Lung cancer is the most common cancer in males worldwide. The principal mode of treatment in the early stage of non-small cell lung cancer (NSCLC) is surgery. However, five-year survival is only about 15% for all stages. The aim is to investigate the effect of daily low dose cisplatin concurrently with radiation therapy in advanced NSCLC patients with poor performance status. Materials and Methods: Ten patients diagnosed as inoperable Stage IIIB NSCLC with comorbid disease were assessed retrospectively in Bezmialem Vakif University, Faculty of Medicine, Department of Radiation Oncology, between 2011 to 2013. ECOG performance status was between 3 and 4. Cisplatin was administered at 6mg/m2 daily, for 5 days a week concurrently with radiotherapy using 160-200 cGy daily fractions, 54 Gy being the lowest and 63 Gy being the highest dose. Results: Complete response at the primary tumour site was obtained in 20% patients. Grade I esophagitis was seen 70 percent of patients, and the grade II haematological toxicity rate was 20 %. Median survival time was 7 months. Conclusions: Median survival time was reasonable, despite the patients ECOG performance status of 3-4, which is similar to groups even without comorbid disorders in comparison to other published papers in the literature. Acceptable toxicity, high response rates and quality of life of patients are the other favourable features.

No Thumbnail Available
PublicationMetadata only

Düşük doz radyoterapi volümlerinin akciğer kanseri hastalarında yaşam üzerine etkileri

2017-07-01, KIZILTAN, HURİYE ŞENAY, MAYADAĞLI, ALPASLAN, ERİŞ, ALİ HİKMET, KABLAN, ÖZGÜR, EROĞUZ, SEZGİ TURAN, EVRİM, EVREN, ALTINOK SÜT, PELİN, TEKÇE, ERTUĞRUL, GÜNEŞ BAYIR, AYŞE, KIRSEVER, ESRA, KIZILTAN, HURİYE ŞENAY, MAYADAĞLI, ALPASLAN, ERİŞ, ALİ HİKMET, KABLAN, ÖZGÜR, ALTINOK SÜT, PELİN, TEKÇE, ERTUĞRUL, GÜNEŞ BAYIR, AYŞE

No Thumbnail Available
PublicationMetadata only

A Pilot Study of Self-Reported Physical Activity and Eating Habits in Turkish Cancer Patients Under Chemotherapy

2015-08-18, Gunes-Bayir, AYŞE, Kiziltan, HURİYE ŞENAY, Sentuerk, Nidanur, Mayadagli, ALPASLAN, GUMUS, Mahmut, GÜNEŞ BAYIR, AYŞE, KIZILTAN, HURİYE ŞENAY, MAYADAĞLI, ALPASLAN

As in all individuals, improving the quality of life, balanced nutrition and physical activity habits must be acquired in cancer patients. The purpose of this study was to determine eating habits and physical activity of cancer patients receiving chemotherapy. Sixty-six patients were completed the questionnaire included sociodemographic data, type of cancer, anthropometric measurements (size and body weight), dietary and physical activity habits. Body mass index for each patient was calculated. Data were analyzed using Statistical Package for Social Science software. Patients were ranged from underweight to obese according to their body mass index: 6.1% of patients were classified as underweight. Almost half (48.5%, n = 32) reported to be regularly physical active, and 46.9% (n = 15) thereof reported 30min brisk walking. More vegetables consumption was the most popular answer with 62.1% (n = 41), whereas vegetables/fruit or vegetables/legume consumption was 22.7% (n = 15). Gender differences in food choice and preferring the taste of food were not seen as statistically significant. In this article, patients with different types of cancer reported their eating habits and physical activity. Disease-related and worse prognostic factors were found. An institutional program should be offered to cancer patients for consulting about nutrition and physical activity.